Categories: Stocks / ETFs

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial

Recent Posts

July 26 — Heart Fit Clinic

Heart Fit Clinic on Talk to the Experts at 11 a.m. on QR Calgary. There’s…

42 minutes ago

From South Korea to Semiconductors: Top ETF Inflows

The ETF market saw inflows shift notably this past week, as investors funneled capital toward…

2 hours ago

Lebanese return to ‘pilot zone’ villages they say Israel never occupied | Israel attacks Lebanon News

Southern Lebanon – Dozens of displaced residents have begun to return to villages in southern Lebanon,…

2 hours ago

Chainlink CCIP Joins Central Bank Digital Asset Pilots

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Reference: Chainlink…

2 hours ago

Homicide of Edmonton mom and nurse Nadine Robinson unsolved, 20 years later – Edmonton

It’s been 20 years since Royal Alexandra Hospital nurse Nadine Robinson was found dead in…

4 hours ago

World Markets Watchlist: July 20, 2026

Our global markets watchlist tracks nine prominent indexes from economies around the world. The list…

7 hours ago